Is it useful to continue administration of gonadotropin releasing hormone (GnRH) agonist after embryo transfer?
Completed
- Conditions
- Infertility treated by ICSIPregnancy and ChildbirthIn vitro fertilization
- Registration Number
- ISRCTN13123887
- Lead Sponsor
- The Egyptian IVF Center (Egypt)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Female
- Target Recruitment
- 446
Inclusion Criteria
Women under 40 years old undergoing intracytoplasmic sperm injection (ICSI) in the first or second trial and using the long GnRHa protocol
Exclusion Criteria
1. Donor eggs
2. Patients aged 40 or older
3. Pre-implantation Genetic Diagnosis (PGD) cycles
4. Patients with fibroids or congenital anomalies of the uterus
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Clinical pregnancy rate, which is measured by BhCG assay 2 weeks after embryo transfer followed by ultrasound at 6?7 weeks to detect fetal echoes and pulsation
- Secondary Outcome Measures
Name Time Method Ongoing pregnancy rate, which is diagnosed by ultrasound examination at 20?24 weeks pregnancy to document a viable pregnancy at this point